Detalhe da pesquisa
1.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251312
2.
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis Rheumatol
; 73(10): 1835-1846, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34042314
3.
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
Vaccine
; 39(44): 6454-6459, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600751
4.
Temporomandibular joint involvement in rheumatoid arthritis patients: association between clinical and tomographic data.
Acta Odontol Latinoam
; 29(3): 123-129, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383601